The COVID-19 Pandemic May Cause a Long-Term Disruption to Cancer Care

SAP Partners | Health System / Oncology | <b>Association of Community Cancer Centers</b>

Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers, about how the COVID-19 pandemic is going to impact cancer mortality.

Pharmacy Times® interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers and medical director at Ann B. Barshinger Cancer Institute, Penn Medicine in Lancaster PA about how the coronavirus disease 2019 (COVID-19) pandemic is going to impact cancer mortality.

The full conversation can be found in the video above.

Related Content:

Association of Community Cancer CentersInterviewsCoronavirusHospitalOncology
Ribociclib Offers Improved Overall Survival in Postmenopausal Patients with HR-Positive, HER2-Negative Advanced Breast Cancer
Study: Interprofessional Collaboration Reduces Incidence of Hospital-Onset C. Difficile
Study: Half of Patients Hospitalized With COVID-19 Have at Least 1 Symptom 2 Years Later